This linear, covalently closed, double-stranded DNA offers a rapid, cell-free alternative to traditional plasmid DNA, addressing a critical bottleneck in nucleic acid therapeutics development
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
The trial will enroll up to 42 patients in Finland across four cohorts
The conflict is also triggering a widening public health emergency
Nearly 12 million people are estimated to be living with glaucoma, making the country one of the worst affected globally
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
The data highlights its RSV vaccine cuts hospitalizations in older adults
The approval follows the pivotal Phase III ARANOTE trial, which demonstrated that darolutamide plus ADT cut the risk of radiological progression or death by 46% compared to placebo plus ADT
Glucon-D maintained its leadership position with a 59% MAT market share
Subscribe To Our Newsletter & Stay Updated
